Skip to content

Functional Outcome After Cardiac Arrest

Functional Outcome After Cardiac Arrest; Prediction and Prognosis Factors for Patients Awake Within the First 15 Days

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02292147
Acronym
HANOX
Enrollment
140
Registered
2014-11-17
Start date
2013-03-13
Completion date
2017-10-20
Last updated
2020-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Out of Hospital Cardiac Arrest

Keywords

Cerebral anoxia, Functional outcome

Brief summary

Descriptive and prognosis study of the functional outcome after cardiac arrest for the patients awake within the first 15 days.

Detailed description

Functional outcome after cerebral anoxia due to cardiac arrest is poorly documented.. Survival after out of hospital cardiac arrest has improved and long term follow up of the patients is not routinely effective. Patients showing sign of awakening very early are considered in a good outcome group. Nevertheless they can experience some restriction and difficulties when they try to return to their premorbid level of functioning. We aim to study their long term functional outcome and their level of anxiety, depression, quality of life and caregiver burden as well as their general cognitive functioning. Prognosis factors will be studied in the acute phase.

Interventions

None listed

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

: * age 18 to 85 * Out of hospital cardiac arrest ; cardiac arrest in the ER is eligible * Glasgow Coma Score ≥ 12 within 15 days after onset * Living in the parisian area

Exclusion criteria

: * no social security * Neurological condition (multiple sclerosis, parkinson disease, AMS, stroke) priori to the cardiac arrest * Psychiatric condition (schizophrenia, severe bipolar syndrome, long term neuroleptic medication, autistic spectrum disorders * Deafness and blindness * Neoplasia * Premorbid limitation of autonomy. * Difficulties in speaking and writing the French language

Design outcomes

Primary

MeasureTime frameDescription
Glasgow outcome Scale Extended score18 monthsFunctional outcome at 18 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026